EMAIL THIS PAGE TO A FRIEND

Cancer research

Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis.


PMID 25269481

Abstract

Caveolin-2 (Cav-2), a member of caveolin protein family, is largely different from better known caveolin-1 (Cav-1) and thus might play distinct functions. Here, we provide the first genetic evidence suggesting that host-expressed Cav-2 promotes subcutaneous tumor growth and tumor-induced neovascularization using two independent syngeneic mouse models. Host deficiency in Cav-2 resulted in defective and reduced growth of subcutaneously implanted Lewis lung carcinoma (LLC) and B16-F10 melanoma tumors, respectively. Consistent with the defective growth, LLC and B16-F10 melanoma tumors implanted into Cav-2 KO mice displayed reduced microvascular density (MVD) determined by IHC with anti-CD31 antibodies, suggesting impaired pathologic angiogenesis. Additional studies involving LLC tumors extracted from Cav-2 KO mice just 10 days after implantation determined reduced cell proliferation, massive necrotic cell death, and fibrosis. In contrast with day 10, only MVD but not cell proliferation and survival was reduced in the earliest palpable LLC tumors extracted 6 days after implantation into Cav-2 KO mice, suggesting that impaired angiogenesis is the causative factor. Mechanistically, impaired LLC tumor growth and angiogenesis in Cav-2 KO mice was associated with increased expression levels of antiangiogenic thrombospondin-1 and inhibited S1177 phosphorylation of endothelial nitric oxide synthase. Taken together, our data suggest that host deficiency in Cav-2 impairs tumor-induced angiogenesis, leading to compromised tumor cell survival/proliferation manifested by the defective tumor growth. In conclusion, host-expressed Cav-2 may promote tumor growth via supporting tumor-induced angiogenesis. Thus, Cav-2 expressed in tumor microenvironment may potentially become a novel target for cancer therapy.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2501669
Anti-CASP3 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
GW10811F Anti-CD34 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300690
Anti-CD34 antibody produced in rabbit, affinity isolated antibody
SAB1406243
Anti-PECAM1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1408616
Anti-PECAM1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
WH0000836M2 Monoclonal Anti-CASP3 antibody produced in mouse, clone 4D3, purified immunoglobulin, buffered aqueous solution
C5737 Monoclonal Anti-Caspase 3 antibody produced in mouse, clone 84803.111, purified immunoglobulin, lyophilized powder
SAB4700463
Monoclonal Anti-CD31 antibody produced in mouse, clone MEM-05, purified immunoglobulin, buffered aqueous solution
WH0000947M1
Monoclonal Anti-CD34 antibody produced in mouse, clone 5F3, purified immunoglobulin, buffered aqueous solution
SAB1403649
Monoclonal Anti-CD34 antibody produced in mouse, clone 5A6, purified immunoglobulin, buffered aqueous solution
SAB4700160 Monoclonal Anti-CD34 antibody produced in mouse, clone 4H11[APG], purified immunoglobulin, buffered aqueous solution
SAB4700736 Monoclonal Anti-CD34 antibody produced in mouse, clone 581, purified immunoglobulin, buffered aqueous solution
WH0005175M1
Monoclonal Anti-PECAM1 antibody produced in mouse, clone 1D2-1A5, purified immunoglobulin, buffered aqueous solution
P0878
O-Phospho-L-serine
C3H8NO6P